AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zicla M 60mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Zicla M 60mg/500mg Tablet SR

Diabetic patients using the dual-action antidiabetic medication, Zicla M 60mg/500mg SR tablets, should adhere to a consistent daily dosage taken with meals. This medication, a combination therapy for adult type 2 diabetes, effectively manages blood glucose. Dosage adjustments are determined by your physician based on your individual blood sugar response and should be followed meticulously. Discontinuing Zicla M without medical consultation poses serious risks including hyperglycemia, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Remember, Zicla M is one component of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and nausea. Prompt glucose ingestion (e.g., sugary foods or juice) is crucial to manage hypoglycemic episodes. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects are altered taste perception, diarrhea, abdominal pain, headaches, upper respiratory infections, and weight gain. Inform your doctor of any pre-existing heart conditions before commencing treatment. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Pregnant or lactating women should seek medical advice. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Zicla M 60mg/500mg Tablet SR

Non-insulin-dependent diabetes

Major Benefits of Zicla M 60mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Zicla M 60mg/500mg Extended-Release tablets with a meal.

Common Side effects of Zicla M 60mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Zicla M 60mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Zicla M 60mg/500mg Extended-Release Tablets with food.

How Zicla M 60mg/500mg Tablet SR works:

Zicla M SR tablets (60mg/500mg) combine gliclazide and metformin, both agents used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Zicla M 60mg/500mg SR tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Zicla M 60mg/500mg sustained-release tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Zicla M 60mg/500mg tablets may pose a risk during lactation. Available human data indicate potential transfer to breast milk, potentially harming the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

For individuals with kidney impairment, the use of Zicla M 60mg/500mg SR tablets requires careful consideration. Dosage modification of Zicla M 60mg/500mg SR tablets may be necessary. Physician consultation is recommended. In patients exhibiting severe kidney disease, Zicla M 60mg/500mg SR tablets are contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

The extended-release Zicla M 60mg/500mg tablet requires careful administration in individuals with hepatic impairment. Dosage modification of Zicla M 60mg/500mg extended-release tablets may be necessary. Physician consultation is advised. Initiation of Zicla M 60mg/500mg extended-release tablets generally begins with a reduced dose for patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Zicla M 60mg/500mg Tablet SR :

Should you forget a Zicla M 60mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zicla M 60mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Zicla M 60mg/500mg Tablet SR

Zicla M 60mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Zicla M 60mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Zicla M 60mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as tablets, honey, or fruit juice.
Zicla M 60mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is best avoided in individuals with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zicla M 60mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Zicla M 60mg/500mg Tablet SR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zicla M 60mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Zicla M 60mg/500mg SR tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Zicla M 60mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Zicla M 60mg/500mg SR Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Zicla M 60mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Zicla M 60mg/500mg Tablet SR can cause lactic acidosis (MALA), a serious, though rare, complication of metformin. This medical emergency results from excessive blood lactic acid. Risk factors include kidney disease, advanced age, and high alcohol consumption. Symptoms such as muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or slow heart rate necessitate immediate discontinuation of Zicla M and consultation with your doctor.
Prolonged use of Zicla M 60mg/500mg Tablet SR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Patients allergic to Zicla M 60mg/500mg Tablet SR components or excipients, or those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining Zicla M 60mg/500mg SR tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Zicla M 60mg/500mg Tablet...
110
MRP 127
13% off